All News #Library
Others
Spyre Therapeutics Reports Q4 2025 Financial Results
19 Feb 2026 //
GLOBENEWSWIRE
Spyre Therapeutics Highlights 2025 Priorities And Pipeline Updates
13 Jan 2025 //
PR NEWSWIRE
Spyre Therapeutics Doses First Participants In SPY001 Phase 1 Trial For IBD
18 Jun 2024 //
PR NEWSWIRE
Spyre Therapeutics Q1 2024 Financials, Corporate Update
09 May 2024 //
PR NEWSWIRE
Spyre Therapeutics Announces $180 Million Private Placement
18 Mar 2024 //
PRESS RELEASE
Spyre Therapeutics Announces Grants of Inducement Awards
01 Mar 2024 //
PRESS RELEASE

Market Place
Sourcing Support